Stockreport

Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference

Indaptus Therapeutics, Inc.  (INDP) 
PDF NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative canc [Read more]